38934386|t|Effects of P301L-TAU on post-translational modifications of microtubules in human iPSC-derived cortical neurons and TAU transgenic mice.
38934386|a|ABSTRACT: TAU is a microtubule-associated protein that promotes microtubule assembly and stability in the axon. TAU is missorted and aggregated in an array of diseases known as tauopathies. Microtubules are essential for neuronal function and regulated via a complex set of post-translational modifications (PTMs), changes of which affect microtubule stability and dynamics, microtubule interaction with other proteins and cellular structures, and mediate recruitment of microtubule-severing enzymes. As impairment of microtubule dynamics causes neuronal dysfunction, we hypothesize cognitive impairment in human disease to be impacted by impairment of microtubule dynamics. We therefore aimed to study the effects of a disease-causing mutation of TAU (P301L) on the levels and localization of microtubule PTMs indicative of microtubule stability and dynamics, to assess whether P301L-TAU causes stability-changing modifications to microtubules. To investigate TAU localization, phosphorylation, and effects on tubulin PTMs, we expressed wild-type or P301L-TAU in human MAPT-KO induced pluripotent stem cell-derived neurons (iNeurons) and studied TAU in neurons in the hippocampus of mice transgenic for human P301L-TAU (pR5 mice). Human neurons expressing the longest TAU isoform (2N4R) with the P301L mutation showed increased TAU phosphorylation at the AT8, but not the p-Ser-262 epitope, and increased polyglutamylation and acetylation of microtubules compared with endogenous TAU-expressing neurons. P301L-TAU showed pronounced somatodendritic presence, but also successful axonal enrichment and a similar axodendritic distribution comparable to exogenously expressed 2N4R-wildtype-TAU. P301L-TAU-expressing hippocampal neurons in transgenic mice showed prominent missorting and tauopathy-typical AT8-phosphorylation of TAU and increased polyglutamylation, but reduced acetylation, of microtubules compared with non-transgenic littermates. In sum, P301L-TAU results in changes in microtubule PTMs, suggestive of impairment of microtubule stability. This is accompanied by missorting and aggregation of TAU in mice but not in iNeurons. Microtubule PTMs/impairment may be of key importance in tauopathies.
38934386	11	16	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	17	20	TAU	Gene	4137
38934386	76	81	human	Species	9606
38934386	116	119	TAU	Gene	4137
38934386	131	135	mice	Species	10090
38934386	147	150	TAU	Gene	4137
38934386	156	186	microtubule-associated protein	Gene	151393
38934386	201	212	microtubule	Disease	MESH:C567137
38934386	249	252	TAU	Gene	4137
38934386	314	325	tauopathies	Disease	MESH:D024801
38934386	476	487	microtubule	Disease	MESH:C567137
38934386	512	523	microtubule	Disease	MESH:C567137
38934386	608	619	microtubule	Disease	MESH:C567137
38934386	641	666	impairment of microtubule	Disease	MESH:C567137
38934386	683	703	neuronal dysfunction	Disease	MESH:D009461
38934386	720	740	cognitive impairment	Disease	MESH:D003072
38934386	744	749	human	Species	9606
38934386	776	801	impairment of microtubule	Disease	MESH:C567137
38934386	885	888	TAU	Gene	4137
38934386	890	895	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	931	942	microtubule	Disease	MESH:C567137
38934386	962	973	microtubule	Disease	MESH:C567137
38934386	1016	1021	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	1022	1025	TAU	Gene	4137
38934386	1098	1101	TAU	Gene	4137
38934386	1188	1193	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	1194	1197	TAU	Gene	4137
38934386	1201	1206	human	Species	9606
38934386	1207	1211	MAPT	Gene	4137
38934386	1284	1287	TAU	Gene	4137
38934386	1321	1325	mice	Species	10090
38934386	1341	1346	human	Species	9606
38934386	1347	1352	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	1353	1356	TAU	Gene	4137
38934386	1362	1366	mice	Species	10090
38934386	1369	1374	Human	Species	9606
38934386	1406	1409	TAU	Gene	4137
38934386	1434	1439	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	1466	1469	TAU	Gene	4137
38934386	1618	1621	TAU	Gene	4137
38934386	1642	1647	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	1648	1651	TAU	Gene	4137
38934386	1824	1827	TAU	Gene	4137
38934386	1829	1834	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	1835	1838	TAU	Gene	4137
38934386	1884	1888	mice	Species	10090
38934386	1921	1930	tauopathy	Disease	MESH:D024801
38934386	1962	1965	TAU	Gene	4137
38934386	2090	2095	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
38934386	2096	2099	TAU	Gene	4137
38934386	2122	2133	microtubule	Disease	MESH:C567137
38934386	2154	2179	impairment of microtubule	Disease	MESH:C567137
38934386	2244	2247	TAU	Gene	4137
38934386	2251	2255	mice	Species	10090
38934386	2277	2288	Microtubule	Disease	MESH:C567137
38934386	2333	2344	tauopathies	Disease	MESH:D024801
38934386	Association	MESH:D003072	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
38934386	Association	MESH:D024801	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
38934386	Association	MESH:C567137	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
38934386	Association	MESH:D003072	4137
38934386	Association	MESH:C567137	4137
38934386	Association	MESH:D024801	4137

